Related Experiment Video
Updated: Nov 26, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output
Md Imtiaz Khalil1, Ishita Ghosh1, Vibha Singh1
1Department of Biochemistry and Molecular Biology, LSU Health Sciences Center, Shreveport, LA 71130, USA.
Abstract:
Most prostate cancer (PCa) deaths result from progressive failure in standard androgen deprivation therapy (ADT), leading to metastatic castration-resistant PCa (mCRPC); however, the mechanism and key players leading to this are not fully understood. While studying the role of tousled-like kinase 1 (TLK1) and never in mitosis gene A (NIMA)-related kinase 1 (NEK1) in a DNA damage response (DDR)-mediated cell cycle arrest in LNCaP cells treated with bicalutamide, we uncovered that overexpression of wt-NEK1 resulted in a rapid conversion to androgen-independent (AI) growth, analogous to what has been observed when YAP1 is overexpressed. We now report that overexpression of wt-NEK1 results in accumulation of YAP1, suggesting the existence of a TLK1>NEK1>YAP1 axis that leads to adaptation to AI growth. Further, YAP1 is co-immunoprecipitated with NEK1. Importantly, NEK1 was able to phosphorylate YAP1 on six residues in vitro, which we believe are important for stabilization of the protein, possibly by increasing its interaction with transcriptional partners. In fact, knockout (KO) of NEK1 in NT1 PCa cells resulted in a parallel decrease of YAP1 level and reduced expression of typical YAP-regulated target genes. In terms of cancer potential implications, the expression of NEK1 and YAP1 proteins was found to be increased and correlated in several cancers. These include PCa stages according to Gleason score, head and neck squamous cell carcinoma, and glioblastoma, suggesting that this co-regulation is imparted by increased YAP1 stability when NEK1 is overexpressed or activated by TLK1, and not through transcriptional co-expression. We propose that the TLK1>NEK1>YAP1 axis is a key determinant for cancer progression, particularly during the process of androgen-sensitive to -independent conversion during progression to mCRPC.
Insights
A new TLK1>NEK1>YAP1 axis drives prostate cancer progression. This pathway promotes androgen-independent growth, a key step in lethal metastatic castration-resistant prostate cancer (mCRPC).
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Prostate cancer (PCa) deaths often stem from treatment failure, leading to metastatic castration-resistant PCa (mCRPC).
- Mechanisms driving resistance to androgen deprivation therapy (ADT) remain incompletely understood.
- The roles of tousled-like kinase 1 (TLK1) and never in mitosis gene A (NIMA)-related kinase 1 (NEK1) in DNA damage response (DDR) and cell cycle arrest in PCa cells were investigated.
Purpose of the Study:
- To elucidate the role of TLK1, NEK1, and YAP1 in the transition to androgen-independent (AI) growth in prostate cancer.
- To identify the molecular interactions and signaling axis governing AI growth adaptation.
- To explore the clinical relevance of the NEK1-YAP1 interaction in various cancers.
Main Methods:
- Overexpression of wild-type NEK1 (wt-NEK1) in LNCaP cells to observe effects on androgen independence.
- Co-immunoprecipitation assays to detect NEK1-YAP1 interaction.
- In vitro kinase assays to determine NEK1's phosphorylation of YAP1.
- NEK1 knockout (KO) in NT1 PCa cells to assess YAP1 levels and target gene expression.
- Analysis of NEK1 and YAP1 protein expression in clinical cancer samples.
Main Results:
- Overexpression of wt-NEK1 induced rapid androgen-independent (AI) growth, similar to YAP1 overexpression.
- wt-NEK1 overexpression led to YAP1 accumulation, suggesting a TLK1>NEK1>YAP1 signaling axis.
- NEK1 directly phosphorylated YAP1 on six residues in vitro, likely stabilizing the protein.
- NEK1 KO reduced YAP1 levels and YAP-regulated gene expression in PCa cells.
- NEK1 and YAP1 expression were concurrently elevated and correlated in prostate cancer, head and neck squamous cell carcinoma, and glioblastoma.
Conclusions:
- The TLK1>NEK1>YAP1 axis is identified as a critical pathway promoting AI growth and cancer progression.
- NEK1-mediated YAP1 phosphorylation and stabilization are key events in the androgen-sensitive to androgen-independent transition in PCa.
- The NEK1-YAP1 co-regulation has significant implications for understanding and potentially targeting mCRPC and other cancers.
Related Concept Videos
The JAK-STAT Signaling Pathway
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Nuclear Protein Sorting
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
RNA Polymerase II Accessory Proteins

